Alpha-hemolysin variants and uses thereof
AssigneeRoche Sequencing Solutions, Inc.
InventorsTimothy K. CRAIG, Mark R. AMBROSO, Corissa J. HARRIS, Matthew M. DIPIETRO, Yaozhong ZOU, Marshall W. PORTER
Life of this patent
Estimating the term…
Loading patent…
AssigneeRoche Sequencing Solutions, Inc.
InventorsTimothy K. CRAIG, Mark R. AMBROSO, Corissa J. HARRIS, Matthew M. DIPIETRO, Yaozhong ZOU, Marshall W. PORTER
Estimating the term…
Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from V149K, E287R, H35G, T109K, P151K, K147N, E111N, M113A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. The α-hemolysin variants may also include a substitution at H144A and/or a series of glycine residues spanning residues 127 to 131 of the mature, wild-type alpha hemolysin. Also provided are nanopore assemblies including the alpha-hemolysin variants, the assembly having a decreased time-to-thread. The decreased time-to-thread, for example, increases DNA sequencing efficiency and accuracy.
A system for sequencing a nucleic acid comprising:
A method for sequencing a target nucleic acid sequence, comprising:
An α-hemolysin variant comprising an amino acid sequence selected from the group consisting of:
Dependencies are inferred from the claim text.